STRAP Knockdown Inhibits Migration and Growth of Non-Small Cell Lung Cancer

X Chen1, C Xu1, Y Yang1

  • 1Department of Respiratory, the Second People's Hospital of Lanzhou, Lanzhou, China.

Insights

Serine-threonine kinase receptor-associated protein (STRAP) is highly expressed in non-small cell lung cancer (NSCLC). Inhibiting STRAP suppresses NSCLC cell migration, invasion, and tumor growth, offering a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Serine-threonine kinase receptor-associated protein (STRAP) is implicated in cell proliferation and apoptosis, suggesting a role in tumor development.
  • Understanding STRAP's function in non-small cell lung cancer (NSCLC) is crucial for identifying potential therapeutic strategies.

Purpose of the Study:

  • To investigate the role and mechanism of STRAP in non-small cell lung cancer (NSCLC) progression.
  • To evaluate the therapeutic potential of targeting STRAP in NSCLC.

Main Methods:

  • Quantitative reverse transcription PCR, immunohistochemical staining, and Western blotting were used to assess STRAP expression in NSCLC tissues and cells.
  • In vitro studies involved siRNA-mediated knockdown of STRAP in NSCLC cell lines (A549, HCC827) to evaluate effects on cell migration, invasion, and apoptosis-related protein expression (XIAP, caspase-3, caspase-9).
  • In vivo experiments utilized a nude mouse model to assess the impact of STRAP inhibition on tumor growth.

Main Results:

  • STRAP was found to be significantly overexpressed in NSCLC tissues and cells.
  • Knockdown of STRAP expression using siRNA led to a significant inhibition of NSCLC cell migration and invasion.
  • STRAP inhibition altered the expression of apoptosis-related proteins, decreasing XIAP and increasing caspase-3 and caspase-9 levels.
  • In vivo, suppression of STRAP expression retarded tumor growth in a nude mouse model.

Conclusions:

  • STRAP is oncogenic in NSCLC, evidenced by its overexpression and promotion of cell migration and invasion.
  • Targeting STRAP, through gene knockdown, effectively inhibits NSCLC progression both in vitro and in vivo.
  • STRAP represents a promising therapeutic target for non-small cell lung cancer treatment.